Timing Protocol

When to Take GLP-1 Agonists — Expert Timing Protocols

Expert-analyzed timing recommendations for glp-1 agonists based on what 5 longevity researchers say about when, how, and what to take it with.

Based on expert consensus data from publicly available videos, not medical advice. Always consult your healthcare provider before starting, stopping, or changing any supplement.

Quick Timing Guide

Once-weekly injection. No specific time-of-day requirement. Must be combined with strength training and high protein intake (minimum 1g per pound of lean body mass) to mitigate muscle loss (Attia).

2.6/5

Moderate Consensus

on GLP-1 Agonists overall

Full Protocol

Timing

Once-weekly injection. No specific time-of-day requirement. Must be combined with strength training and high protein intake (minimum 1g per pound of lean body mass) to mitigate muscle loss (Attia).

Dosage

Semaglutide: typically starts at 0.25mg/week, titrated up to 2.4mg/week for weight management. Tirzepatide: starts at 2.5mg/week, titrated up to 15mg/week. Dosing is individualized by a prescribing physician (Attia).

Form

Injectable (subcutaneous, once weekly). Oral formulations are in development. Some clinicians use compounded peptide formulations at lower doses (Attia, Koniver).

Notes

This is a prescription medication — not a supplement. Requires physician oversight, regular monitoring via DEXA scans for body composition, and blood work. Compounded versions from reputable pharmacies may offer lower-dose options. High cost remains a significant barrier to access (Attia). Hyman strongly advocates addressing diet and lifestyle first before considering pharmaceutical intervention.

Expert Positions

Andrew Huberman
Andrew Huberman
Favorable — Covers Science Extensively
Peter Attia
Peter Attia
Strongly Favorable with Caveats
Rhonda Patrick
Rhonda Patrick
Limited Direct Coverage
Bryan Johnson
Bryan Johnson
Limited Direct Coverage
Mark Hyman
Mark Hyman
Strongly Opposes Widespread Use

What Each Expert Says About Timing

Andrew Huberman
Andrew Huberman
Favorable — Covers Science Extensively

Huberman covers GLP-1 agonists across multiple contexts: hunger neuroscience, peptide therapy, and fat loss protocols. He features Dr. Zachary Knight (UCSF) explaining the mechanism of GLP-1 drugs, their origin from Gila monster venom, and the evolution from short-acting to long-acting forms. He discusses how GLP-1 acts on brain stem and hypothalamic circuits to suppress appetite. In peptide therapy episodes, Dr. Craig Koniver discusses micro-dosing semaglutide and tirzepatide to mitigate side effects. Huberman also frequently mentions yerba mate as a natural GLP-1 stimulator for fat loss.

Unlock the Full Picture

Go beyond the consensus — see exactly what each expert says about glp-1 agonists.

  • Per-expert timing protocols & reasoning
  • Interaction warnings & disagreements
  • Video citations with timestamps
View Full Report

Related Timing Guides